<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29262" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Specific Phobia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Samra</surname>
            <given-names>Chandan K.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Torrico</surname>
            <given-names>Tyler J.</given-names>
          </name>
          <aff>Consilient Interventional Psychiatry</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Abdijadid</surname>
            <given-names>Sara</given-names>
          </name>
          <aff>UCLA</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Chandan Samra declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Tyler Torrico declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sara Abdijadid declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>8</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29262.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Specific phobia is a common anxiety disorder.&#x000a0;Patients with specific phobias experience anxiety and panic attacks along with unreasonable fear of exposure or anticipated exposure to a phobic stimulus. The anxiety response goes beyond normal apprehension and leads to avoidance behavior.&#x000a0;The intensity of the fear is often disproportionate to the actual danger posed by the phobic stimulus. This activity outlines the current DSM-5-TR diagnostic criteria for specific phobia,&#x000a0;shedding light on validated assessment tools and evidence-based treatments, notably focusing on the amalgamation of therapeutic methods for enhanced patient outcomes.&#x000a0;Emphasizing interprofessional collaboration, this session underscores the necessity of a holistic approach involving psychiatrists, psychologists, and allied healthcare professionals in managing patients with specific phobia.&#x000a0;</p>
        <p>Furthermore, the&#x000a0;course discussion highlights the historical evolution of understanding phobias, from ancient observations to Freudian conceptualizations as psychological defense mechanisms and the subsequent influence of behaviorism on the perception of phobic behavior as learned responses. Advancements in neuroscience and the role of the amygdala in fear processing contribute to the contemporary understanding of specific phobias. The evolution of therapeutic approaches, encompassing behavior therapy like systematic desensitization and the prominence of cognitive-behavioral therapy, reflects the ongoing development of interventions grounded in psychological and neurobiological understanding. This activity aims to equip healthcare professionals with updated knowledge and comprehensive strategies to diagnose, assess, and treat specific phobia, recognizing its impact on patients' quality of life and social functioning.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Differentiate specific phobia from other anxiety disorders based on DSM-5-TR diagnostic criteria and clinical presentation.</p></list-item><list-item><p>Implement validated assessment tools effectively during clinical evaluations for&#x000a0;a thorough&#x000a0;diagnosis of specific phobia.&#x000a0;</p></list-item><list-item><p>Select the most appropriate evidence-based treatment modalities for specific phobia, aligned with patient preferences, comorbidities, and treatment goals.</p></list-item><list-item><p>Collaborate with the interprofessional team to enhance clinical outcomes for patients with specific phobia.&#x000a0;</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29262&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29262">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-29262.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Anxiety describes an uncomfortable emotional state characterized by inner turmoil and dread over anticipated future events. Anxiety&#x000a0;is closely related to and overlaps with fear, which is a response to perceived and actual threats. Anxiety often results in nervousness, rumination, pacing, and somatization. Every human experiences anxiety because it is an evolved behavioral response to prepare an individual to detect and deal with threats.<xref ref-type="bibr" rid="article-29262.r1">[1]</xref>&#x000a0;Anxiety&#x000a0;becomes pathological when&#x000a0;it is so overwhelming that there is persistent distress, a decrease in the quality of life, and impairment in regular major life activities.<xref ref-type="bibr" rid="article-29262.r2">[2]</xref></p>
        <p>Anxiety disorders are common psychiatric disorders and are often underrecognized.<xref ref-type="bibr" rid="article-29262.r3">[3]</xref>&#x000a0;Untreated anxiety disorders can significantly impair the quality of life, lead to comorbid psychiatric conditions, and interfere with social functioning.<xref ref-type="bibr" rid="article-29262.r4">[4]</xref><xref ref-type="bibr" rid="article-29262.r5">[5]</xref>&#x000a0;Individuals with anxiety disorders may experience a poorer quality of life&#x000a0;compared to those without anxiety disorders, and the severity of anxiety can impact daily functioning.<xref ref-type="bibr" rid="article-29262.r6">[6]</xref></p>
        <p>Specific phobia is an anxiety disorder characterized by excessive and irrational fear of a particular object, situation, or activity. The anxiety response goes beyond normal apprehension and leads to avoidance behavior.&#x000a0;The intensity of the fear is often disproportionate to the actual danger posed by the phobic stimulus. Common examples of specific phobias include fear of heights (acrophobia), fear of spiders (arachnophobia), fear of flying (aviophobia), and fear of needles (trypanophobia). People with specific phobias may experience intense anxiety or panic attacks when exposed to the feared object or situation.<xref ref-type="bibr" rid="article-29262.r7">[7]</xref></p>
        <p>Historically, extreme fears of specific situations or objects have been documented as far back as the ancient Greeks and Romans. In the late 19th and early 20th centuries, Sigmund Freud proposed that phobias were a psychological defense mechanism arising from repressed psychological conflict.&#x000a0;These ideas influenced early psychological thought on phobias but were later critiqued and expanded upon.<xref ref-type="bibr" rid="article-29262.r8">[8]</xref> In the early 20th century, behaviorism became a dominant force in psychology&#x02014;researchers like John B. Watson and B.F. Skinner emphasized observable behaviors and learning through conditioning. Phobias were often seen as learned responses, with specific phobias thought to develop through classical conditioning (associating a neutral stimulus with a negative experience).</p>
        <p>The Diagnostic and Statistical Manual of Mental Disorders (DSM) is a key resource for classifying mental health disorders; in its various editions, specific phobias have been included and refined. The DSM-III (1980) marked a significant step in systematically classifying phobias.&#x000a0;Advances in neuroscience and research have contributed to a better understanding of the neural mechanisms underlying specific phobias, including insights into the role of the amygdala, a brain region involved in processing fear.<xref ref-type="bibr" rid="article-29262.r7">[7]</xref></p>
        <p>Over time, therapeutic approaches for specific phobias have evolved. Behavior therapy, including systematic desensitization (a type of exposure therapy), has been a key component. Cognitive behavioral therapy has also become a prominent and effective approach, focusing on changing negative thought patterns and behaviors associated with phobias.&#x000a0;Today, specific phobias are recognized as a common type of anxiety disorder, and treatment approaches continue to evolve based on ongoing research and a deeper understanding of the psychological and neurobiological factors involved.<xref ref-type="bibr" rid="article-29262.r9">[9]</xref></p>
      </sec>
      <sec id="article-29262.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of most psychiatric conditions involves&#x000a0;various&#x000a0;degrees and types of biological, psychological, and social contributors. Although psychological factors particularly impact the development of anxiety disorders, there are multiple biological components to pathological anxiety. The study of inheritance patterns has revealed a general familial aggregation among major anxiety disorders.<xref ref-type="bibr" rid="article-29262.r10">[10]</xref>&#x000a0;Twin studies have demonstrated stronger inheritance patterns for monozygotic twins&#x000a0;compared to dizygotic twins, suggesting a genetic component to the development of pathological anxiety.<xref ref-type="bibr" rid="article-29262.r11">[11]</xref>&#x000a0;Although the study of anxiety and gene-environment interactions is limited, it is known that epigenetic mechanisms, particularly DNA methylation, contribute to mediating transcription factors for stress-related genes, which may underlie the development of pathological anxiety.<xref ref-type="bibr" rid="article-29262.r12">[12]</xref></p>
        <p>Behavioral scientists have contributed significantly to uncovering the psychological mechanisms contributing to anxiety. Conditioned responses of learned fear are more significant among anxiety-disordered individuals compared&#x000a0;to controls, with an explanation of&#x000a0;2 likely mechanisms: first, there is greater excitatory conditioning to danger cues, and second, there is impaired inhibitory conditioning to safety signals.<xref ref-type="bibr" rid="article-29262.r13">[13]</xref>&#x000a0;</p>
        <p>Parenting behaviors implicate cross-generational influences on the development of childhood anxiety. These parenting behavioral systems include vicarious learning, social referencing, and modeling of parental anxiety. Furthermore, overly protective and overly critical parenting styles, parental response to child anxiety, and family accommodation of a child's anxiety all contribute to the conditioning and development of childhood anxiety.<xref ref-type="bibr" rid="article-29262.r14">[14]</xref>&#x000a0;Children of parents&#x000a0;with depression and anxiety disorders are at a higher risk of developing a depressive or anxiety disorder.<xref ref-type="bibr" rid="article-29262.r15">[15]</xref>&#x000a0;Another mechanism for developing a specific phobia is through modeling, in which a person observes a reaction in another person and internalizes that other person's fears or warnings about the dangers of a specific object or situation.<xref ref-type="bibr" rid="article-29262.r16">[16]</xref></p>
      </sec>
      <sec id="article-29262.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Anxiety disorders are among the most common mental health disorders, with an estimated prevalence of 5% to 34% worldwide, affecting both children and adults.<xref ref-type="bibr" rid="article-29262.r17">[17]</xref><xref ref-type="bibr" rid="article-29262.r18">[18]</xref><xref ref-type="bibr" rid="article-29262.r19">[19]</xref>&#x000a0;Lifetime 12-month prevalence estimates for specific phobia range from 7.7% to 12.5%; these estimates are maintained through different surveyed populations around the world.<xref ref-type="bibr" rid="article-29262.r20">[20]</xref><xref ref-type="bibr" rid="article-29262.r21">[21]</xref><xref ref-type="bibr" rid="article-29262.r22">[22]</xref><xref ref-type="bibr" rid="article-29262.r23">[23]</xref><xref ref-type="bibr" rid="article-29262.r24">[24]</xref><xref ref-type="bibr" rid="article-29262.r25">[25]</xref>&#x000a0;The incidence rates for specific phobia are estimated to be 26.9% for individuals between 20 and 50 years.<xref ref-type="bibr" rid="article-29262.r25">[25]</xref><xref ref-type="bibr" rid="article-29262.r26">[26]</xref>&#x000a0;Prevalence rates are higher in females compared to males,<xref ref-type="bibr" rid="article-29262.r27">[27]</xref>&#x000a0;and they decrease with age.<xref ref-type="bibr" rid="article-29262.r28">[28]</xref><xref ref-type="bibr" rid="article-29262.r29">[29]</xref>&#x000a0;Sequentially,&#x000a0;the most frequent types of specific phobias are those with stimuli related to animals, the natural environment, and then blood-injection-injury&#x02013;related stimuli.<xref ref-type="bibr" rid="article-29262.r30">[30]</xref></p>
      </sec>
      <sec id="article-29262.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Neuroanatomically, the amygdala is classically associated with provoking a fear response when stimulated. The amygdala and other fear-related neurocircuitry may share a similar neuroanatomy to anxiety neurocircuitry.<xref ref-type="bibr" rid="article-29262.r31">[31]</xref>&#x000a0;The amygdala and its connections to the frontal cortex (perirhinal cortex, ventrolateral prefrontal cortex, anterior insula) have received the most attention.<xref ref-type="bibr" rid="article-29262.r32">[32]</xref>&#x000a0;As the amygdala is part of the limbic system, other limbic system structures likely contribute to the development of anxiety, with a specific interest in the hippocampus, as it plays an integral role in fear learning and extinction.<xref ref-type="bibr" rid="article-29262.r33">[33]</xref>&#x000a0;Functional magnetic resonance imaging (fMRI) studies have found that hypofunction of the prefrontal cortex and anterior cingulate cortex is associated with emotional dysregulation and cognitive dysfunction in those with anxiety.<xref ref-type="bibr" rid="article-29262.r34">[34]</xref></p>
        <p>The activation of fear neurocircuitry, with presumed&#x000a0;anxiety neurocircuitry overlap, involves the release of various neurochemicals that lead to sympathetic stimulation. Classically characterized as a "fight-or-flight" reaction, this sympathetic response evolved to be adaptive and for a prompt behavioral response to avoid&#x000a0;actual or perceived danger.<xref ref-type="bibr" rid="article-29262.r1">[1]</xref>&#x000a0;However, this response can be conditioned to over-activate, leading to pathological anxiety even when exposure to threat is low or should be low.<xref ref-type="bibr" rid="article-29262.r13">[13]</xref>&#x000a0;The neurochemicals involved in producing a fight-or-flight response are&#x000a0;numerous and include norepinephrine, epinephrine, cortisol, neurosteroids, and vasopressin.<xref ref-type="bibr" rid="article-29262.r35">[35]</xref>&#x000a0;Dopamine likely&#x000a0;has a modulatory role in producing anxiety-like behavior.<xref ref-type="bibr" rid="article-29262.r36">[36]</xref>&#x000a0;Low activity of postsynaptic serotonin 5-HT1A receptors contributes to pathological anxiety, which has led to the development of pharmacotherapy attempting to modulate these receptors to reduce anxiety.<xref ref-type="bibr" rid="article-29262.r37">[37]</xref></p>
      </sec>
      <sec id="article-29262.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The presentation of specific phobia is variable. The chief complaint may be related to anxiety or impaired functioning in their social responsibilities due to symptoms of their illness. The chief complaint will likely be related to significant fear or anxiety in the presence of a specific situation or object, known as the phobic stimulus. It is essential to investigate if there is a single phobic stimulus or multiple. The anxiety reaction to the phobic stimulus must be greater than the expected reaction for the general population. In presence of the phobic stimuli, the anxiety must be severe, and it can produce panic attacks in certain cases. Anticipation of exposure to phobic stimuli may also induce anxiety. The anxiety reaction is anticipated to evoke nearly every time there is exposure to the phobic stimulus.&#x000a0;Children may express fear or anxiety by crying, tantrums, freezing, or clinging.</p>
        <p>In specific phobia, the individual actively avoids the phobic stimulus, and this is termed active avoidance. Examples of active avoidance include taking a longer driving route to avoid a bridge, avoiding grass and gardens due to concern for spiders or insects, and refusing to&#x000a0;visit a doctor&#x000a0;due to fear of needles or medical procedures. Some active avoidance may be obvious, but certain behaviors are subtle, such as refusing to look at certain movies or books that may potentially have a phobic stimulus. Active avoidance may impact regular functioning, including social relationships and occupational responsibilities.&#x000a0;</p>
        <p>The mental status examination is completed in psychiatric evaluations and has a variable presentation in specific phobia; however, the following areas should be carefully considered:</p>
        <list list-type="bullet">
          <list-item>
            <p>Behavior: When discussing the phobic stimulus, does the patient have anxious behaviors, such as constant movement, shaking, and small tremors?&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Speech:&#x000a0;Is the patient's tone frightened when speaking about the phobic stimulus?&#x000a0;Does the patient actively try and change the conversation away from the topic of the phobic stimulus?</p>
          </list-item>
          <list-item>
            <p>Affect: Is the patient always anxious or&#x000a0;only in the context of the phobic stimulus?</p>
          </list-item>
          <list-item>
            <p>Thought&#x000a0;process: Is the patient's thought process logical when thinking and discussing the phobic stimulus?&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Insight:&#x000a0;What is the patient's understanding of their exaggerated response to the phobic stimulus?</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29262.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Individuals with suspected specific phobia should be referred for a psychiatric evaluation.<xref ref-type="bibr" rid="article-29262.r38">[38]</xref>&#x000a0;The initial goals are to develop rapport with the patient, obtain historical information in detail from the patient, and conduct a mental status examination. Evaluation for&#x000a0;applicable DSM-5-TR diagnostic criteria should be&#x000a0;performed&#x000a0;to make a formal diagnosis.&#x000a0;</p>
        <p>
<bold>DSM-5-TR Criteria for&#x000a0;Specific Phobia</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Marked fear or anxiety about a specific object or situation (flying, heights, animals, seeing blood, or other). In children the fear&#x000a0;or anxiety may be expressed by crying, tantrums, freezing, or clinging.</p>
          </list-item>
          <list-item>
            <p>The phobic object or situation almost always provokes immediate fear or anxiety.</p>
          </list-item>
          <list-item>
            <p>The phobic object or situation is actively avoided or endured with intense fear or anxiety.</p>
          </list-item>
          <list-item>
            <p>The fear or anxiety is out of proportion to the actual danger posed by the specific object or situation and to the sociocultural context.</p>
          </list-item>
          <list-item>
            <p>The fear, anxiety, or avoidance is persistent, typically lasting for 6 months or more.</p>
          </list-item>
          <list-item>
            <p>The fear, anxiety, or avoidance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.</p>
          </list-item>
          <list-item>
            <p>The disturbances are not better explained by the symptoms of another mental disorder, including fear, anxiety, and avoidance of situations associated with panic-like symptoms; objects or situations related to obsessions; reminders of traumatic events; separation anxiety; or social situations</p>
          </list-item>
        </list>
        <p>Specify<italic toggle="yes">&#x000a0;</italic>if:</p>
        <list list-type="order">
          <list-item>
            <p>Animal (spiders, insects, dogs, etc)</p>
          </list-item>
          <list-item>
            <p>Natural environment (heights, storms, water, etc)</p>
          </list-item>
          <list-item>
            <p>Blood-injection-injury (needles, invasive medical procedures)</p>
          </list-item>
          <list-item>
            <p>Situational (airplanes, elevators, enclosed places)</p>
          </list-item>
          <list-item>
            <p>Other (situations that may lead to choking or vomiting, loud sounds, costumed characters)</p>
          </list-item>
        </list>
        <p>
<bold>Screening Tools</bold>
</p>
        <p>Multiple screening tools for anxiety disorders exist and have wide availability and validation. Generalized anxiety disorder screeners are common and widely available for adult screening, however most broader anxiety disorder screeners were designed to screen for anxiety disorders in children. When there is difficulty in obtaining the full diagnostic criteria from the interview alone, implementing a validated screening tool can be helpful in the diagnosis of specific phobia and in identifying possible comorbid conditions.&#x000a0;</p>
        <p>
<bold>Screen for Child Anxiety&#x02013;Related Emotional Disorders&#x000a0;</bold>
</p>
        <p>Screen for Child Anxiety&#x02013;Related Emotional Disorders (SCARED) is one of the most commonly used assessment tools for diagnosing anxiety disorders in children. SCARED is a child and parent self-report measure evaluated in numerous settings worldwide.<xref ref-type="bibr" rid="article-29262.r39">[39]</xref>&#x000a0;Various versions&#x000a0;and revisions of the questionnaire have been developed. The&#x000a0;most commonly used version consists of 41 questions.&#x000a0;The total score is based on&#x000a0;5 subscale scores for the most common pediatric anxiety disorders:</p>
        <list list-type="order">
          <list-item>
            <p>Generalized anxiety disorder</p>
          </list-item>
          <list-item>
            <p>Social phobia</p>
          </list-item>
          <list-item>
            <p>Social anxiety disorder (SAD)</p>
          </list-item>
          <list-item>
            <p>Somatic symptoms or panic disorder</p>
          </list-item>
          <list-item>
            <p>School phobia.</p>
          </list-item>
        </list>
        <p>Each response is scored between 0 and 2,&#x000a0;with a total score of 25 or higher having high sensitivity and specificity for discriminating between anxiety and nonanxiety disorders.<xref ref-type="bibr" rid="article-29262.r39">[39]</xref>&#x000a0;A 55% or higher reduction in the total score with treatment best predicts treatment response and a 60% or higher reduction in parent SCARED scores predicts remission.<xref ref-type="bibr" rid="article-29262.r39">[39]</xref>&#x000a0;There is a modified version of SCARED, the Screen for Adult Anxiety Related Disorders (SCAARED), available to screen adults for similar anxiety disorders as children.&#x000a0;</p>
        <p>The SCARED assessment tool can be used free of charge with an acceptable time burden on clinicians and families, making it an excellent tool for diagnosing and managing anxiety disorders in children. SCARED cutoffs can also be used to guide treatment. For example, an insufficient reduction in the SCARED score after an adequate trial of behavioral therapy may indicate the need for pharmacotherapy.<xref ref-type="bibr" rid="article-29262.r39">[39]</xref>&#x000a0;Studies have shown some discordance in the information provided by the child and parent on this questionnaire without apparent contributory factors.<xref ref-type="bibr" rid="article-29262.r38">[38]</xref>&#x000a0;More research is warranted to understand the cause of "low informant agreement" and what factors contribute to this discrepancy. Still, the SCARED assessment tool is considered&#x000a0;a stable, reliable, valid, and sensitive measure of anxiety, despite the informant discrepancy, which interestingly also stays stable over time.&#x000a0;The SCARED screening tool has shown&#x000a0;strict measurement invariance and solid test-retest reliability.</p>
        <p>
<bold>Youth Anxiety Measure </bold>
</p>
        <p>Youth Anxiety Measure (YAM) is a new parent-child questionnaire developed to assess anxiety disorder symptoms in children and adolescents according to the DSM-5. The scale consists of&#x000a0;2 parts: part I consists of 28 items and measures the major anxiety disorders;&#x000a0;part II contains 22 items relating to specific phobias and agoraphobia.<xref ref-type="bibr" rid="article-29262.r40">[40]</xref>&#x000a0;The validation study for this questionnaire reports acceptable "face validity" with items successfully linked to the intended anxiety disorders and phobias. The authors report good internal consistency and reliability of the new measure with the parent-child agreement and concurrent, convergent, divergent, and discriminant validity.<xref ref-type="bibr" rid="article-29262.r40">[40]</xref>&#x000a0;An analysis of the psychometric qualities of the scale with the collection of normative data in nonclinical and clinical populations is still needed.</p>
        <p>
<bold>Anxiety Disorder Interview Schedule&#x000a0;</bold>
</p>
        <p>Anxiety Disorder Interview Schedule (ADIS) is a well-validated diagnostic interview suitable for measuring all anxiety disorders, mood disorders, and attention-deficit&#x000a0;or attention-deficit hyperactivity disorder in children.&#x000a0;The ADIS is a&#x000a0;semistructured diagnostic interview that primarily assesses child anxiety disorders, and the diagnoses are derived from interviews with both the child and the parent.<xref ref-type="bibr" rid="article-29262.r41">[41]</xref>&#x000a0;The interviews cover the entire range of anxiety-related disorders outlined by the DSM-5.&#x000a0;Each diagnosis is assigned a clinician severity rating (CSR), a symptoms severity rating, and a functional impairment rating.</p>
        <p>A CSR of 4 or higher is required to provide a particular diagnosis. If the child and parent interviews yield different diagnoses and CSRs, the interviewer makes a composite diagnosis using recommended guidelines in the clinician manual.&#x000a0;The ADIS's parent and child versions possess high inter-rater and test-retest reliability. One study reported&#x000a0;almost perfect agreement on both the child and parent interview for diagnosing an anxiety disorder using ADIS. They also report almost perfect agreement regarding the severity of the primary diagnosis.<xref ref-type="bibr" rid="article-29262.r40">[40]</xref>&#x000a0;The ADIS is considered the gold-standard diagnostic evaluation for anxiety disorders.&#x000a0;</p>
        <p>
<bold>Pediatric Anxiety Rating Scale&#x000a0;</bold>
</p>
        <p>Pediatric Anxiety Rating Scale (PARS) is a clinician-rated scale of anxiety severity using the frequency of distress symptoms, avoidance behaviors, and interference in daily functioning.<xref ref-type="bibr" rid="article-29262.r40">[40]</xref>&#x000a0;In a multisite study evaluating 128 children&#x000a0;aged&#x000a0;6 to 17,&#x000a0;PARS was shown to have high inter-rater reliability, adequate test-retest reliability, and fair internal consistency.&#x000a0;PARS scores are sensitive to treatment and parallel change in other measures of anxiety symptoms. This assessment tool has been validated in various populations and is frequently used worldwide in clinical and research settings.<xref ref-type="bibr" rid="article-29262.r42">[42]</xref></p>
      </sec>
      <sec id="article-29262.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The optimal treatment strategy for specific phobia is cognitive&#x000a0;behavioral therapy. However, cognitive&#x000a0;behavioral therapy can be a challenging treatment modality for some patients to tolerate. Therefore, it is important to consider, if treatment is indicated in each individual case of specific&#x000a0;phobia. Assessment of the impact that specific phobia has on quality of life, levels of distress, and social and occupational functioning, can help determine the individualized level of necessity to intervene or not.<xref ref-type="bibr" rid="article-29262.r9">[9]</xref>&#x000a0;Medication interventions can be considered alternative treatments for specific phobia; however, no medications have been cleared by the FDA for this purpose.&#x000a0;</p>
        <p>Cognitive&#x000a0;behavioral therapy in specific phobia is generally limited to exposure therapy, which can be emotionally taxing and challenging for patients to complete a full course of treatment. Exposure therapy utilizes systematic desensitization. This implements the principles of&#x000a0;classical conditioning and can be enhanced in combination with operant conditioning approaches such as adding reinforcement or punishment that leads to extinction.&#x000a0;In methodical desensitization, the patient is exposed to a list of stimuli ranking from the least to the most anxiety-provoking. With this method, patients are taught various techniques to deal with anxiety, such as relaxation, breathing control, and&#x000a0;alternative cognitive approaches.</p>
        <p>The cognitive-behavioral approach includes reinforcing the realization that the phobic stimulus is safe. As the patient masters these techniques, they are taught to use them in the face of anxiety-provoking stimuli and induce relaxation. As the patients become desensitized to each stimulus on the scale, they keep moving up until the most anxiety-provoking stimuli no longer elicit any fear or anxiety.<xref ref-type="bibr" rid="article-29262.r43">[43]</xref><xref ref-type="bibr" rid="article-29262.r44">[44]</xref>&#x000a0;</p>
        <p>Flooding, also known as implosion, is another behavioral technique that can be used to treat specific phobias. This technique involves increasing exposure to the stimulus to induce habituation and decrease anxiety.&#x000a0;To be successful, behavioral therapy requires that the patient be committed to the treatment, there are distinctly&#x000a0;identified problems and objectives, and there are alternative strategies for dealing with the patient&#x02019;s feelings.<xref ref-type="bibr" rid="article-29262.r9">[9]</xref></p>
        <p>Patients with a blood-injection-injury phobia are advised to tense their bodies and remain seated during the exposure to avoid the possibility of fainting from a vasovagal reaction. Also, beta-blockers and benzodiazepines can be used in patients when the phobia is associated with panic attacks.<xref ref-type="bibr" rid="article-29262.r9">[9]</xref></p>
        <p>Other forms of treatment that may also be considered include virtual therapy, in which the patient is exposed to or interacts with the phobic stimulus on a computer screen. This field of treatment is relatively novel and requires more research. Other treatment modalities include hypnosis, supportive therapy, and family therapy. The goal of all forms of therapy is to help the patient recognize that the feared stimulus is not dangerous and to provide emotional support.<xref ref-type="bibr" rid="article-29262.r45">[45]</xref><xref ref-type="bibr" rid="article-29262.r46">[46]</xref></p>
      </sec>
      <sec id="article-29262.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnoses for specific phobia include:</p>
        <p>
<bold>Agoraphobia</bold>
</p>
        <p>Specific phobia may resemble agoraphobia. However, in specific phobia, the phobic stimulus is specific to a particular situation rather than a general fear of difficulty escaping.&#x000a0;</p>
        <p>
<bold>Panic Disorder</bold>
</p>
        <p>Panic attacks can occur in specific phobia. Panic disorder is another anxiety disorder, in which panic attacks occur uncued or unexpected. This is in contrast to specific phobia, when panic attacks can occur after exposure to the phobic stimulus.&#x000a0;</p>
        <p>
<bold>Social Anxiety Disorder</bold>
</p>
        <p>Social anxiety disorder describes a general fear of being publicly scrutinized, embarrassed, or judged negatively by others in a variety of contexts.&#x000a0;</p>
        <p>
<bold>Posttraumatic Stress Disorder&#x000a0;</bold>
</p>
        <p>Avoidance is a key feature of&#x000a0;Posttraumatic Stress Disorder (PTSD). However, in PTSD, the avoidance is related to situations associated with the trauma. To distinguish these disorders, the panel of symptoms needs to be taken into consideration. PTSD is expected to have persisting affective symptoms, while specific phobia (outside of the phobic stimulus) is not.&#x000a0;</p>
        <p>
<bold>Separation Anxiety Disorder</bold>
</p>
        <p>Separation anxiety is primarily a disorder of childhood, however, it can occur in adults as well. Separation anxiety disorder describes the fear of being separated from an attachment figure, while specific phobia results in anxiety when exposed to a phobic stimulus.&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-29262.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Patients who are able to complete a course of cognitive&#x000a0;behavioral therapy (exposure therapy) have a promising prognosis, but it is improved when there is maintenance therapy to ensure remission of symptoms.<xref ref-type="bibr" rid="article-29262.r9">[9]</xref>&#x000a0;Treatment response with benzodiazepines has been more limited to the duration treated with medication, and the treatment gains do not persist after discontinuation of the medication.<xref ref-type="bibr" rid="article-29262.r9">[9]</xref>&#x000a0;For those with limited response or difficulty tolerating cognitive&#x000a0;behavioral therapy, utilizing a step-wise approach of pharmacotherapy to control severe anxiety and then proceeding to cognitive&#x000a0;behavioral therapy may be appropriate.&#x000a0;</p>
      </sec>
      <sec id="article-29262.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Uncontrolled specific phobia increases the risk of other comorbid psychiatric illnesses, specifically depression. Specific phobias can have significant impairment to social and occupational functioning, which can worsen psychological stress.&#x000a0;Anxiety disorders are a risk factor for suicidality, even after controlling for co-occurring mental health disorders and life stress.<xref ref-type="bibr" rid="article-29262.r47">[47]</xref>&#x000a0;Estimates of population-attributable risk suggested a 7% to 10% risk of suicidality in adolescent patients with anxiety disorders.<xref ref-type="bibr" rid="article-29262.r47">[47]</xref></p>
      </sec>
      <sec id="article-29262.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Exposure therapy is known to be a helpful treatment intervention for specific phobia; however, it is challenging for patients to endure and requires creative approaches to navigate a successful treatment course. For individuals with severe anxiety related to specific phobia, it may be optimal to initiate psychopharmacology treatment to treat symptoms prior to initiating exposure therapy.&#x000a0;The goal of psychopharmacological intervention is to facilitate the patient's capacity to proceed with a course of exposure therapy. During a course of exposure therapy, the appropriate degree of thought process remodeling and encouragement is needed in order to keep patients motivated to continue through the treatment course.<xref ref-type="bibr" rid="article-29262.r9">[9]</xref><xref ref-type="bibr" rid="article-29262.r48">[48]</xref></p>
      </sec>
      <sec id="article-29262.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The diagnosis and management of&#x000a0;specific phobia require the efforts of a coordinated interprofessional healthcare team.&#x000a0;Both pediatric and adult providers are likely to encounter patients suffering from specific phobia.&#x000a0;Multiple studies show that patients with anxiety disorders tend to have more frequent medical visits and increased healthcare utilization rates, especially for comorbid medical conditions or somatic complaints. Individuals with suspected specific phobia should&#x000a0;be promptly referred for a behavioral health evaluation&#x000a0;by a psychiatrist.</p>
        <p>Barriers to appropriate diagnosis and treatment of patients with specific phobia include time constraints, unfamiliarity with diagnosing and managing anxiety disorders, concerns of stigmatizing patients, and reluctance to speak with parents or adult patients about mental illness. To overcome these barriers, there have been increased efforts in developing collaborative care models for training clinicians to identify and refer patients with anxiety disorders to psychiatric professionals in-clinic or by telehealth.<xref ref-type="bibr" rid="article-29262.r49">[49]</xref>&#x000a0;</p>
        <p>Once the diagnosis is made, patients may require intensive psychotherapy and psychoeducation to benefit from the treatment plan and understand expected outcomes. The clinical nurse plays a crucial role in educating parents and caregivers, reinforcing the techniques learned in therapy so they may be practiced at home. When pharmacotherapy is initiated, the clinical pharmacist assists in monitoring for adverse effects of the medications prescribed, performing medication reconciliation, and offering patient medication counseling. A collaborative interprofessional team of clinicians, behavioral therapists, nurses, and pharmacists can optimize clinical outcomes for specific phobia and help decrease the global burden of this disease.&#x000a0;</p>
      </sec>
      <sec id="article-29262.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29262&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29262">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/mental-health/specific-phobia-excessive-fear-of-a-particular-object-situation-or-activity/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=29262">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29262/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29262">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-29262.s15">
        <title>References</title>
        <ref id="article-29262.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bateson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brilot</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Nettle</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Anxiety: an evolutionary approach.</article-title>
            <source>Can J Psychiatry</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>56</volume>
            <issue>12</issue>
            <fpage>707</fpage>
            <page-range>707-15</page-range>
            <pub-id pub-id-type="pmid">22152639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weisberg</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Overview of generalized anxiety disorder: epidemiology, presentation, and course.</article-title>
            <source>J Clin Psychiatry</source>
            <year>2009</year>
            <volume>70 Suppl 2</volume>
            <fpage>4</fpage>
            <page-range>4-9</page-range>
            <pub-id pub-id-type="pmid">19371500</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walter</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Bukstein</surname>
                <given-names>OG</given-names>
              </name>
              <name>
                <surname>Abright</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Keable</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ramtekkar</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Ripperger-Suhler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rockhill</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders.</article-title>
            <source>J Am Acad Child Adolesc Psychiatry</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>59</volume>
            <issue>10</issue>
            <fpage>1107</fpage>
            <page-range>1107-1124</page-range>
            <pub-id pub-id-type="pmid">32439401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bittner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Egger</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Erkanli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jane Costello</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Foley</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Angold</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>What do childhood anxiety disorders predict?</article-title>
            <source>J Child Psychol Psychiatry</source>
            <year>2007</year>
            <month>Dec</month>
            <volume>48</volume>
            <issue>12</issue>
            <fpage>1174</fpage>
            <page-range>1174-83</page-range>
            <pub-id pub-id-type="pmid">18093022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ezpeleta</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Keeler</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Erkanli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Costello</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Angold</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of psychiatric disability in childhood and adolescence.</article-title>
            <source>J Child Psychol Psychiatry</source>
            <year>2001</year>
            <month>Oct</month>
            <volume>42</volume>
            <issue>7</issue>
            <fpage>901</fpage>
            <page-range>901-14</page-range>
            <pub-id pub-id-type="pmid">11693585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Olatunji</surname>
                <given-names>BO</given-names>
              </name>
              <name>
                <surname>Cisler</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Tolin</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>Quality of life in the anxiety disorders: a meta-analytic review.</article-title>
            <source>Clin Psychol Rev</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>27</volume>
            <issue>5</issue>
            <fpage>572</fpage>
            <page-range>572-81</page-range>
            <pub-id pub-id-type="pmid">17343963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garcia</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Neurobiology of fear and specific phobias.</article-title>
            <source>Learn Mem</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>24</volume>
            <issue>9</issue>
            <fpage>462</fpage>
            <page-range>462-471</page-range>
            <pub-id pub-id-type="pmid">28814472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Compton</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The psychoanalytic view of phobias. Part I: Freud's theories of phobias and anxiety.</article-title>
            <source>Psychoanal Q</source>
            <year>1992</year>
            <month>Apr</month>
            <volume>61</volume>
            <issue>2</issue>
            <fpage>206</fpage>
            <page-range>206-29</page-range>
            <pub-id pub-id-type="pmid">1594716</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thng</surname>
                <given-names>CEW</given-names>
              </name>
              <name>
                <surname>Lim-Ashworth</surname>
                <given-names>NSJ</given-names>
              </name>
              <name>
                <surname>Poh</surname>
                <given-names>BZQ</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Recent developments in the intervention of specific phobia among adults:&#x000a0;a&#x000a0;rapid review.</article-title>
            <source>F1000Res</source>
            <year>2020</year>
            <volume>9</volume>
            <pub-id pub-id-type="pmid">32226611</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Bryant</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Separation Anxiety Disorder.</article-title>
            <source>JAMA</source>
            <year>2021</year>
            <month>Nov</month>
            <day>09</day>
            <volume>326</volume>
            <issue>18</issue>
            <fpage>1880</fpage>
            <pub-id pub-id-type="pmid">34751707</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>B&#x000f6;gels</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Knappe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Adult separation anxiety disorder in DSM-5.</article-title>
            <source>Clin Psychol Rev</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>33</volume>
            <issue>5</issue>
            <fpage>663</fpage>
            <page-range>663-74</page-range>
            <pub-id pub-id-type="pmid">23673209</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Battaglia</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Separation anxiety: at the neurobiological crossroads of adaptation and illness.</article-title>
            <source>Dialogues Clin Neurosci</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>277</fpage>
            <page-range>277-85</page-range>
            <pub-id pub-id-type="pmid">26487808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brew</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Lundholm</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gong</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Larsson</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Almqvist</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>The familial aggregation of atopic diseases and depression or anxiety in children.</article-title>
            <source>Clin Exp Allergy</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>48</volume>
            <issue>6</issue>
            <fpage>703</fpage>
            <page-range>703-711</page-range>
            <pub-id pub-id-type="pmid">29513367</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lissek</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Powers</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>McClure</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Phelps</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Woldehawariat</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Grillon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pine</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Classical fear conditioning in the anxiety disorders: a meta-analysis.</article-title>
            <source>Behav Res Ther</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>43</volume>
            <issue>11</issue>
            <fpage>1391</fpage>
            <page-range>1391-424</page-range>
            <pub-id pub-id-type="pmid">15885654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lebowitz</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Leckman</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Silverman</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Cross-generational influences on childhood anxiety disorders: pathways and mechanisms.</article-title>
            <source>J Neural Transm (Vienna)</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>123</volume>
            <issue>9</issue>
            <fpage>1053</fpage>
            <page-range>1053-67</page-range>
            <pub-id pub-id-type="pmid">27145763</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Campos</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bret&#x000f3;n-L&#x000f3;pez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Botella</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mira</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Castilla</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mor</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ba&#x000f1;os</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Quero</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of an internet-based exposure treatment for flying phobia (NO-FEAR Airlines) with and without therapist guidance: a randomized controlled trial.</article-title>
            <source>BMC Psychiatry</source>
            <year>2019</year>
            <month>Mar</month>
            <day>06</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>86</fpage>
            <pub-id pub-id-type="pmid">30841930</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kessler</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Petukhova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sampson</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Zaslavsky</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Wittchen</surname>
                <given-names>H -U</given-names>
              </name>
            </person-group>
            <article-title>Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States.</article-title>
            <source>Int J Methods Psychiatr Res</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>169</fpage>
            <page-range>169-84</page-range>
            <pub-id pub-id-type="pmid">22865617</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bandelow</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Michaelis</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of anxiety disorders in the 21st century.</article-title>
            <source>Dialogues Clin Neurosci</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>327</fpage>
            <page-range>327-35</page-range>
            <pub-id pub-id-type="pmid">26487813</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ehrenreich</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Santucci</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Weiner</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>SEPARATION ANXIETY DISORDER IN YOUTH: PHENOMENOLOGY, ASSESSMENT, AND TREATMENT.</article-title>
            <source>Psicol Conductual</source>
            <year>2008</year>
            <month>Jan</month>
            <day>01</day>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>389</fpage>
            <page-range>389-412</page-range>
            <pub-id pub-id-type="pmid">19966943</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kessler</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>McGonagle</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eshleman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wittchen</surname>
                <given-names>HU</given-names>
              </name>
              <name>
                <surname>Kendler</surname>
                <given-names>KS</given-names>
              </name>
            </person-group>
            <article-title>Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.</article-title>
            <source>Arch Gen Psychiatry</source>
            <year>1994</year>
            <month>Jan</month>
            <volume>51</volume>
            <issue>1</issue>
            <fpage>8</fpage>
            <page-range>8-19</page-range>
            <pub-id pub-id-type="pmid">8279933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kessler</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Berglund</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Demler</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Merikangas</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Walters</surname>
                <given-names>EE</given-names>
              </name>
            </person-group>
            <article-title>Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.</article-title>
            <source>Arch Gen Psychiatry</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>62</volume>
            <issue>6</issue>
            <fpage>593</fpage>
            <page-range>593-602</page-range>
            <pub-id pub-id-type="pmid">15939837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bijl</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Ravelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van Zessen</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS).</article-title>
            <source>Soc Psychiatry Psychiatr Epidemiol</source>
            <year>1998</year>
            <month>Dec</month>
            <volume>33</volume>
            <issue>12</issue>
            <fpage>587</fpage>
            <page-range>587-95</page-range>
            <pub-id pub-id-type="pmid">9857791</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Graaf</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>ten Have</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van Gool</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>van Dorsselaer</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of mental disorders and trends from 1996 to 2009. Results from the Netherlands Mental Health Survey and Incidence Study-2.</article-title>
            <source>Soc Psychiatry Psychiatr Epidemiol</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>47</volume>
            <issue>2</issue>
            <fpage>203</fpage>
            <page-range>203-13</page-range>
            <pub-id pub-id-type="pmid">21197531</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alonso</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Angermeyer</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Bernert</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bruffaerts</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Brugha</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Bryson</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>de Girolamo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Graaf</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Demyttenaere</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gasquet</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Haro</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Kessler</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Kovess</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>L&#x000e9;pine</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Ormel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Polidori</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Vilagut</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Almansa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Arbabzadeh-Bouchez</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Autonell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bernal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Buist-Bouwman</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Codony</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Domingo-Salvany</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ferrer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Joo</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez-Alonso</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Matschinger</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mazzi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Morosini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Palac&#x000ed;n</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Romera</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Taub</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Vollebergh</surname>
                <given-names>WA</given-names>
              </name>
              <collab>ESEMeD/MHEDEA 2000 Investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) Project</collab>
            </person-group>
            <article-title>12-Month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project.</article-title>
            <source>Acta Psychiatr Scand Suppl</source>
            <year>2004</year>
            <issue>420</issue>
            <fpage>28</fpage>
            <page-range>28-37</page-range>
            <pub-id pub-id-type="pmid">15128385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wardenaar</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>CCW</given-names>
              </name>
              <name>
                <surname>Al-Hamzawi</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Alonso</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Andrade</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Benjet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bunting</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>de Girolamo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Demyttenaere</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Florescu</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Gureje</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Hisateru</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Karam</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kiejna</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lepine</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Navarro-Mateu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Oakley Browne</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Piazza</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Posada-Villa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ten Have</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Torres</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xavier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zarkov</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Kessler</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>de Jonge</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The cross-national epidemiology of specific phobia in the World Mental Health Surveys.</article-title>
            <source>Psychol Med</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>47</volume>
            <issue>10</issue>
            <fpage>1744</fpage>
            <page-range>1744-1760</page-range>
            <pub-id pub-id-type="pmid">28222820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bijl</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>De Graaf</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ravelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Smit</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vollebergh</surname>
                <given-names>WA</given-names>
              </name>
              <collab>Netherlands Mental Health Survey and Incidence Study</collab>
            </person-group>
            <article-title>Gender and age-specific first incidence of DSM-III-R psychiatric disorders in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS).</article-title>
            <source>Soc Psychiatry Psychiatr Epidemiol</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>37</volume>
            <issue>8</issue>
            <fpage>372</fpage>
            <page-range>372-9</page-range>
            <pub-id pub-id-type="pmid">12195544</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Angst</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Paksarian</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cui</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Merikangas</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Hengartner</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Ajdacic-Gross</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>R&#x000f6;ssler</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>The epidemiology of common mental disorders from age 20 to 50: results from the prospective Zurich cohort Study.</article-title>
            <source>Epidemiol Psychiatr Sci</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>24</fpage>
            <page-range>24-32</page-range>
            <pub-id pub-id-type="pmid">25802979</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stinson</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Dawson</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Patricia Chou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>June Ruan</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Grant</surname>
                <given-names>BF</given-names>
              </name>
            </person-group>
            <article-title>The epidemiology of DSM-IV specific phobia in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions.</article-title>
            <source>Psychol Med</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>37</volume>
            <issue>7</issue>
            <fpage>1047</fpage>
            <page-range>1047-59</page-range>
            <pub-id pub-id-type="pmid">17335637</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sigstr&#x000f6;m</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Skoog</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Karlsson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Nilsson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>&#x000d6;stling</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>NINE-YEAR FOLLOW-UP OF SPECIFIC PHOBIA IN A POPULATION SAMPLE OF OLDER PEOPLE.</article-title>
            <source>Depress Anxiety</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>339</fpage>
            <page-range>339-46</page-range>
            <pub-id pub-id-type="pmid">26645153</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aus&#x000ed;n</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Castellanos</surname>
                <given-names>M&#x000c1;</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and Characterization of Specific Phobia Disorder in People over 65 Years Old in a Madrid Community Sample (Spain) and its Relationship to Quality of Life.</article-title>
            <source>Int J Environ Res Public Health</source>
            <year>2020</year>
            <month>Mar</month>
            <day>15</day>
            <volume>17</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">32183487</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mochcovitch</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>da Rocha Freire</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Nardi</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>A systematic review of fMRI studies in generalized anxiety disorder: evaluating its neural and cognitive basis.</article-title>
            <source>J Affect Disord</source>
            <year>2014</year>
            <volume>167</volume>
            <fpage>336</fpage>
            <page-range>336-42</page-range>
            <pub-id pub-id-type="pmid">25020268</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r32">
          <label>32</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Chu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Marwaha</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sanvictores</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Awosika</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Ayers</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <chapter-title>Physiology, Stress Reaction</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>5</month>
            <day>7</day>
            <pub-id pub-id-type="pmid">31082164</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zarrindast</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Khakpai</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>The Modulatory Role of Dopamine in Anxiety-like Behavior.</article-title>
            <source>Arch Iran Med</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>18</volume>
            <issue>9</issue>
            <fpage>591</fpage>
            <page-range>591-603</page-range>
            <pub-id pub-id-type="pmid">26317601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gordon</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Hen</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The serotonergic system and anxiety.</article-title>
            <source>Neuromolecular Med</source>
            <year>2004</year>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>27</fpage>
            <page-range>27-40</page-range>
            <pub-id pub-id-type="pmid">15001810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vaughan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Coddington</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Ertel</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Separation Anxiety Disorder in School-Age Children: What Health Care Providers Should Know.</article-title>
            <source>J Pediatr Health Care</source>
            <year>2017</year>
            <season>Jul-Aug</season>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>433</fpage>
            <page-range>433-440</page-range>
            <pub-id pub-id-type="pmid">28012800</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Masi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mucci</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Millepiedi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Separation anxiety disorder in children and adolescents: epidemiology, diagnosis and management.</article-title>
            <source>CNS Drugs</source>
            <year>2001</year>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>93</fpage>
            <page-range>93-104</page-range>
            <pub-id pub-id-type="pmid">11460893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karaytu&#x0011f;</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Tamam</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Demirkol</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Naml&#x00131;</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>G&#x000fc;rb&#x000fc;z</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ye&#x0015f;ilo&#x0011f;lu</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Impact of Childhood Trauma and Adult Separation Anxiety Disorder on Quality of Life in Individuals with Schizophrenia.</article-title>
            <source>Neuropsychiatr Dis Treat</source>
            <year>2023</year>
            <volume>19</volume>
            <fpage>181</fpage>
            <page-range>181-196</page-range>
            <pub-id pub-id-type="pmid">36714165</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walkup</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Albano</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Piacentini</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Birmaher</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Compton</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Sherrill</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Ginsburg</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Rynn</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>McCracken</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Waslick</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Iyengar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>March</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Kendall</surname>
                <given-names>PC</given-names>
              </name>
            </person-group>
            <article-title>Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.</article-title>
            <source>N Engl J Med</source>
            <year>2008</year>
            <month>Dec</month>
            <day>25</day>
            <volume>359</volume>
            <issue>26</issue>
            <fpage>2753</fpage>
            <page-range>2753-66</page-range>
            <pub-id pub-id-type="pmid">18974308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCormack</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Mennies</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Silk</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>LB</given-names>
              </name>
            </person-group>
            <article-title>How anxious is too anxious? State and trait physiological arousal predict anxious youth's treatment response to brief cognitive behavioral therapy.</article-title>
            <source>BMC Psychol</source>
            <year>2020</year>
            <month>May</month>
            <day>12</day>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <pub-id pub-id-type="pmid">32398128</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gibby</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Casline</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Ginsburg</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Long-Term Outcomes of Youth Treated for an Anxiety Disorder: A Critical Review.</article-title>
            <source>Clin Child Fam Psychol Rev</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>20</volume>
            <issue>2</issue>
            <fpage>201</fpage>
            <page-range>201-225</page-range>
            <pub-id pub-id-type="pmid">28181040</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Voltas</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hern&#x000e1;ndez-Mart&#x000ed;nez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Arija</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Canals</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The natural course of anxiety symptoms in early adolescence: factors related to persistence.</article-title>
            <source>Anxiety Stress Coping</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>30</volume>
            <issue>6</issue>
            <fpage>671</fpage>
            <page-range>671-686</page-range>
            <pub-id pub-id-type="pmid">28678525</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ginsburg</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Becker-Haimes</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Keeton</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kendall</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Iyengar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sakolsky</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Albano</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Peris</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Compton</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Piacentini</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Results From the Child/Adolescent Anxiety Multimodal&#x000a0;Extended Long-Term Study (CAMELS): Primary Anxiety&#x000a0;Outcomes.</article-title>
            <source>J Am Acad Child Adolesc Psychiatry</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>57</volume>
            <issue>7</issue>
            <fpage>471</fpage>
            <page-range>471-480</page-range>
            <pub-id pub-id-type="pmid">29960692</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spurling</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>McGoldrick</surname>
                <given-names>VP</given-names>
              </name>
            </person-group>
            <article-title>Blood-Injection-Injury (B-I-I) Specific Phobia Affects the Outcome of Hypoxic Challenge Testing.</article-title>
            <source>Aerosp Med Hum Perform</source>
            <year>2017</year>
            <month>May</month>
            <day>01</day>
            <volume>88</volume>
            <issue>5</issue>
            <fpage>503</fpage>
            <page-range>503-506</page-range>
            <pub-id pub-id-type="pmid">28417842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kogan</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Maj</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>First</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Emmelkamp</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Reed</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>The Classification of Anxiety and Fear-Related Disorders in the ICD-11.</article-title>
            <source>Depress Anxiety</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>33</volume>
            <issue>12</issue>
            <fpage>1141</fpage>
            <page-range>1141-1154</page-range>
            <pub-id pub-id-type="pmid">27411108</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zwanzger</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>[Pharmacotherapy of Anxiety Disorders].</article-title>
            <source>Fortschr Neurol Psychiatr</source>
            <year>2016</year>
            <month>May</month>
            <volume>84</volume>
            <issue>5</issue>
            <fpage>306</fpage>
            <page-range>306-14</page-range>
            <pub-id pub-id-type="pmid">27299791</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ori</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Amos</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bergman</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Soares-Weiser</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ipser</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2015</year>
            <month>May</month>
            <day>10</day>
            <volume>2015</volume>
            <issue>5</issue>
            <fpage>CD007803</fpage>
            <pub-id pub-id-type="pmid">25957940</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boden</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Fergusson</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Horwood</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Anxiety disorders and suicidal behaviours in adolescence and young adulthood: findings from a longitudinal study.</article-title>
            <source>Psychol Med</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>431</fpage>
            <page-range>431-40</page-range>
            <pub-id pub-id-type="pmid">17109776</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Becker-Haimes</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Frank</surname>
                <given-names>HE</given-names>
              </name>
            </person-group>
            <article-title>It's all in the name: why exposure therapy could benefit from a new one.</article-title>
            <source>Curr Psychol</source>
            <year>2022</year>
            <month>Jun</month>
            <day>02</day>
            <fpage>1</fpage>
            <page-range>1-7</page-range>
            <pub-id pub-id-type="pmid">35669210</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29262.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramsawh</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Chavira</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Burden of anxiety disorders in pediatric medical settings: prevalence, phenomenology, and a research agenda.</article-title>
            <source>Arch Pediatr Adolesc Med</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>164</volume>
            <issue>10</issue>
            <fpage>965</fpage>
            <page-range>965-72</page-range>
            <pub-id pub-id-type="pmid">20921356</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
